With the peptide level enrichment of the two key glycolytic enzymes ALDOA and PKM in DEM-AD, alongside an indication of general glycolytic dysregulation from STRING analysis, we investigated protein level changes in the levels of all glycolytic enzymes using the same linear regression model used for the peptide level. This evidence concerns the gene ALDOA and Alzheimer disease.